Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Peptide”

209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 209 results

Testing effectiveness (Phase 2)Looking for participantsNCT06345079
What this trial is testing

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumors
Australasian Gastro-Intestinal Trials Group 78
Testing effectiveness (Phase 2)Ended earlyNCT02978222
What this trial is testing

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Platinum Sensitive Ovarian CancerOvarian Cancer
Marker Therapeutics, Inc. 120
Not applicableUnknownNCT05451537
What this trial is testing

Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy

Who this might be right for
Sepsis-Associated Encephalopathy
General Hospital of Ningxia Medical University 100
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Early research (Phase 1)Study completedNCT01302574
What this trial is testing

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Who this might be right for
Taste Disorder, Secondary, Sweet
University Hospital, Basel, Switzerland 16
Testing effectiveness (Phase 2)Study completedNCT02838589
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Who this might be right for
Stroke
Christina Kruuse 30
Early research (Phase 1)Active Not RecruitingNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Early research (Phase 1)Study completedNCT02417688
What this trial is testing

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

Who this might be right for
Carotid Atherosclerosis
Washington University School of Medicine 44
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Early research (Phase 1)Study completedNCT01043146
What this trial is testing

Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide

Who this might be right for
Heart Failure
Corimmun GmbH 50
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Large-scale testing (Phase 3)Looking for participantsNCT07185672
What this trial is testing

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Neuroendocrine Tumor GEP Grade 1-3Neuroendocrine Gastroenteropancreatic Tumour
Tata Memorial Hospital 162
Testing effectiveness (Phase 2)Looking for participantsNCT04997317
What this trial is testing

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Who this might be right for
Meningioma
University Hospital, Basel, Switzerland 18
Not applicableStudy completedNCT04402827
What this trial is testing

Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.

Who this might be right for
Health Care Worker Patient TransmissionReceptor Site AlterationSusceptibility, Disease+1 more
Asociacion para el Estudio de las Enfermedades Infecciosas 140
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Early research (Phase 1)UnknownNCT03291444
What this trial is testing

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Acute Myelogenous (AML)Myelodysplastic Syndromes
Zhujiang Hospital 30
Next Page